Nektar Therapeutics (NKTR)

NCM – Real Time Price. Currency in USD

76.02

+0.52 (0.69%)

Market open: Aug 12, 2026, 3:09 PM EDT

75.50

0.00 (0.00%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

55M

98M

90M

92M

Cost of goods sold

-1M

-32M

-37M

-29M

Gross Profit

54M

66M

53M

63M

Operating expenses (excl. COGS)

-189M

-200M

-191M

-303M

Operating Income

-134M

-133M

-137M

-240M

Non-operating income, total

-21M

14M

-139M

-125M

Pretax income

-155M

-119M

-276M

-365M

Equity in earnings

-9M

Taxes

138K

239K

200K

-3M

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-164M

-119M

-276M

-368M

Discontinued operations

Net income

-164M

-119M

-276M

-368M

Dilution adjustment

Preferred dividends

Nektar Therapeutics (NKTR)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Nektar Therapeutics (NKTR)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Nektar Therapeutics (NKTR)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Nektar Therapeutics (NKTR)

Income Statement (Annual)

Income Statement (Annual)